3H5 Stock Chart & Stats
€0.04
€0.00(0.00%)
At close: 4:00 PM EST
€0.04
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€0.03 - €0.08
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€950.87M
Enterprise Value€2.45B
Total Cash (Recent Filing)€124.21M
Total Debt (Recent Filing)€1.12B
Price to Earnings (P/E)―
Beta0.26
Next Earnings
Aug 31, 2026Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding26,443,615,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)2.41
Price to Sales (P/S)2.88
P/FCF Ratio33.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)€288.94M
Bulls Say, Bears Say
Bulls Say
High Gross MarginA 74.8% gross margin indicates durable service-level pricing power and low direct cost intensity for clinical services. This margin profile provides headroom to absorb SG&A, invest in specialist capabilities and maintain operations during revenue variability, supporting long-term resilience.
Specialist Market FocusA focused franchise on obstetrics, gynaecology, fertility and paediatrics creates sustained demand from maternity and pediatric care. Niche clinical expertise and referral networks raise barriers to entry, supporting stable patient volumes and long-term competitive differentiation.
Diversified Service Revenue StreamsMultiple revenue pillars — inpatient/outpatient, specialist professional fees, fertility and diagnostics — reduce dependence on any single service. This breadth enables cross-selling, higher lifetime patient value, and steadier cash inflows across care cycles over the medium term.
Bears Say
High LeverageA debt-to-equity ratio of 2.38 signals material financial leverage. High interest obligations limit strategic flexibility, increase refinancing risk and amplify earnings volatility during downturns, making capital allocation and growth investments more constrained over months.
Negative ProfitabilityA negative net margin of -12% shows the company is not currently generating profits after operating and financing costs. Sustained unprofitability erodes equity, restricts reinvestment capacity and necessitates either operational turnaround or external funding to restore long-term viability.
Weak Cash Conversion And FCF CollapseA severe FCF contraction (-636%) and OCF to net income of 0.22 indicate poor cash conversion. Weak operating cash flow undermines the ability to service debt, fund capex or support strategic initiatives without relying on external financing, increasing medium-term liquidity risk.
Thomson Medical Group Ltd. News
3H5 FAQ
What was Thomson Medical Group Ltd.’s price range in the past 12 months?
Thomson Medical Group Ltd. lowest stock price was €0.03 and its highest was €0.08 in the past 12 months.
What is Thomson Medical Group Ltd.’s market cap?
Thomson Medical Group Ltd.’s market cap is €950.87M.
When is Thomson Medical Group Ltd.’s upcoming earnings report date?
Thomson Medical Group Ltd.’s upcoming earnings report date is Aug 31, 2026 which is in 62 days.
How were Thomson Medical Group Ltd.’s earnings last quarter?
Thomson Medical Group Ltd. released its earnings results on Feb 11, 2026. The company reported €0 earnings per share for the quarter, the consensus estimate of N/A by €0.
Is Thomson Medical Group Ltd. overvalued?
According to Wall Street analysts Thomson Medical Group Ltd.’s price is currently Overvalued.
Does Thomson Medical Group Ltd. pay dividends?
Thomson Medical Group Ltd. does not currently pay dividends.
What is Thomson Medical Group Ltd.’s EPS estimate?
Thomson Medical Group Ltd.’s EPS estimate is 0.
How many shares outstanding does Thomson Medical Group Ltd. have?
Thomson Medical Group Ltd. has 26,443,615,000 shares outstanding.
What happened to Thomson Medical Group Ltd.’s price movement after its last earnings report?
Thomson Medical Group Ltd. reported an EPS of €0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went up 2.632%.
Which hedge fund is a major shareholder of Thomson Medical Group Ltd.?
Currently, no hedge funds are holding shares in DE:3H5
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Thomson Medical Group Ltd.
Operating as an investment holding company, Thomson Medical Group Limited delivers healthcare services specifically tailored for women and children across Singapore, Malaysia, and Vietnam. Its core assets include the Thomson Medical Centre, alongside an extensive network of affiliated medical clinics and healthcare facilities. The group's service portfolio encompasses immediate care solutions, covering basic resuscitation, ECG, vaccinations, intravenous fluid and antibiotic treatments, minor surgeries and procedures, wound management, and essential diagnostic imaging like X-rays and laboratory tests. Additionally, it provides comprehensive health screening, aesthetic and dermatological services, pain and rehabilitation management, and traditional herbal tea offerings. Furthermore, Thomson Medical Group specializes in a broad spectrum of medical areas. These include women's and children's health, fertility and family planning, ophthalmology, general surgery, urology, preventive health, healthy aging, advanced diagnostic imaging, breast care, cardiology, respiratory and critical care, endocrinology, dermatology, day surgery, general surgical care, counselling, therapy, Traditional Chinese Medicine (TCM), and specialized care for bone, joint, gynecological oncology, dental, and spine conditions. The company's diverse range of products and services are marketed under well-known brands such as Thomson Women's Clinic, Thomson Fertility Centre, Thomson Paediatric Clinic, Thomson Specialists, Thomson Chinese Medicine, Thomson Surgical Centre, Thomson Dental Centre, Thomson Hospital Kota Damansara, TMC Fertility, TMC Care Pharmacy, FV Hospital, and FV Saigon Clinic. Established in 1979, Thomson Medical Group Limited is headquartered in Singapore.
Technical Analysis
Cordlife Group
―
Raffles Medical Group
―
Asiamedic Limited
―
OUE Lippo Healthcare Limited
―
Bangkok Dusit Medical Services Public Co Ltd Shs UnSp Singapore Depositary Receipt Repr 2/1 Sh
―
Options Prices
Currently, No data available
---